| Literature DB >> 33082815 |
Ping Wang1,2, Tie-Feng Sun2, Gang Li1, Hui-Min Zhang2, Fan-Jie Liu3, Zhi-Hui Gao2,4, Sheng-Nan Cao3, Guo-Dong Sun5, Hai-Tao Du4, Cong-An Wang3, Dan-Dan Wang3, Bin Shi3, Ling Lin1.
Abstract
BACKGROUND: Colla Cornus Cervi (CCC) has been used as a traditional Chinese medicine in the treatment of osteoporosis and osteonecrosis of the femoral head. However, the bioavailability of CCC is seriously limited owing to its large molecular weight and complex ingredients. In the present study, antler polypeptide was separated from CCC, and the effects of antler polypeptide on rat bone marrow mesenchymal stem cells (BMSCs) were investigated.Entities:
Year: 2020 PMID: 33082815 PMCID: PMC7563042 DOI: 10.1155/2020/1294151
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
The peptide content of A, B, and C samples determined by the biuret method.
| Samples | Volume (mL) | Average absorbance | Concentration (mg/mL) | Antler polypeptide content (mg/mL) |
|---|---|---|---|---|
| A | 0.7 | 0.291 | 6.319 | 0.602 |
| B | 0.8 | 0.331 | 7.181 | 8.976 |
| C | 0.2 | 0.358 | 7.776 | 38.88 |
Note. Antler polypeptide A (molecular weight <800 Da) sample was concentrated 15 times.
Figure 1HPLC chromatograms of antler polypeptide solutions. Antler polypeptide A molecular weight <800 Da; antler polypeptide B molecular weight 800–1500 Da; antler polypeptide C molecular weight >1500 Da; peptide standard samples, 1, cytochrome C 2, aprotinin, 3, bacillus enzyme, 4, glycine-glycine-tyrosine-arginine, and 5, glycine-glycine-glycine. Elution time: 14.461–15.454 min.
The peak area results of different samples detected by HPLC (n = 3).
| Group | Eluted time/min | Peak area |
|---|---|---|
| A | — | — |
| B | 14.460 | 933.80927 |
| C | 14.907 | 20.30075 |
Note. The peptide peak of different samples with the molecular weight 800–1500 Da eluted at 14.279∼15.351 min.
Figure 2BMSCs observed under an inverted phase contrast microscope. (a) BMSCs cultured with a complex medium for the 2nd day. (b) BMSCs cultured with a complex medium for the 5th day. (c) BMSCs cultured with a complex medium containing antler polypeptide A for the 5th day. (d) BMSCs cultured with a complex medium containing antler polypeptide B for the 5th day. (e) BMSCs cultured with a complex medium containing antler polypeptide C for the 5th day. (f) BMSCs cultured with a complex medium containing Colla Cornus Cervi for the 5th day. Magnification × 200.
Figure 3Effects of different concentrations of antler polypeptide on the proliferation of BMSCs (n = 4); the abscissa showed concentration (g/mL), primary ordinate showed absorbance, and minor ordinate showed the proliferation rate (%).
Figure 4Antler polypeptide B promoted the growth of BMSCs. (a) Cell proliferation assay showed that antler polypeptide B promoted the proliferation of BMSCs (b) Effects of different antler polypeptide groups on the cell cycle of BMSCs. The proliferation index reflected the cell cycle process and proliferative ability of BMSCs. The antler polypeptide B group showed a significantly higher proliferation index. P < 0.05, P < 0.01, P < 0.001, compared with the blank control group.
Figure 5Effect of antler polypeptide on osteogenic differentiation of BMSCs. (a) Antler polypeptide enhanced the ALP activity of BMSCs. (b) Antler polypeptide promoted BMP7 protein expression in BMSCs. P < 0.05, P < 0.01, compared with the blank control group.